- Home
- APDN vs BCDA Comparison
APDN vs BCDA Comparison
Compare APDN & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APDN
- BCDA
- Stock Information
- Founded
- APDN 1983
- BCDA N/A
- Country
- APDN United States
- BCDA United States
- Employees
- APDN N/A
- BCDA N/A
- Industry
- APDN Other Consumer Services
- BCDA Biotechnology: Pharmaceutical Preparations
- Sector
- APDN Consumer Discretionary
- BCDA Health Care
- Exchange
- APDN Nasdaq
- BCDA Nasdaq
- Market Cap
- APDN 8.9M
- BCDA 7.9M
- IPO Year
- APDN N/A
- BCDA N/A
- Fundamental
- Price
- APDN $0.23
- BCDA $2.05
- Analyst Decision
- APDN Strong Buy
- BCDA Strong Buy
- Analyst Count
- APDN 1
- BCDA 1
- Target Price
- APDN $1.50
- BCDA $25.00
- AVG Volume (30 Days)
- APDN 8.7M
- BCDA 31.3K
- Earning Date
- APDN 12-17-2024
- BCDA 11-13-2024
- Dividend Yield
- APDN N/A
- BCDA N/A
- EPS Growth
- APDN N/A
- BCDA N/A
- EPS
- APDN N/A
- BCDA N/A
- Revenue
- APDN $3,431,420.00
- BCDA $71,000.00
- Revenue This Year
- APDN N/A
- BCDA N/A
- Revenue Next Year
- APDN $48.01
- BCDA N/A
- P/E Ratio
- APDN N/A
- BCDA N/A
- Revenue Growth
- APDN N/A
- BCDA N/A
- 52 Week Low
- APDN $0.12
- BCDA $1.84
- 52 Week High
- APDN $14.40
- BCDA $10.80
- Technical
- Relative Strength Index (RSI)
- APDN 46.35
- BCDA 42.16
- Support Level
- APDN $0.12
- BCDA $2.00
- Resistance Level
- APDN $0.25
- BCDA $2.14
- Average True Range (ATR)
- APDN 0.04
- BCDA 0.16
- MACD
- APDN 0.01
- BCDA -0.00
- Stochastic Oscillator
- APDN 51.62
- BCDA 15.91
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).